{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:06:47Z","timestamp":1794013607048,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12325-014-0094-z","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T09:17:57Z","timestamp":1390295877000},"page":"168-179","source":"Crossref","is-referenced-by-count":12,"title":["Incremental Burden of Disease in Patients Diagnosed with Pulmonary Arterial Hypertension Receiving Monotherapy and Combination Vasodilator Therapy"],"prefix":"10.1007","volume":"31","author":[{"given":"Mark","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cerulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"issue":"9","key":"94_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","volume":"173","author":"M Humbert","year":"2006","unstructured":"Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France Results from a National Registry. Am J Respir Crit Care Med. 2006;173(9):1023\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"94_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","volume":"30","author":"AJ Peacock","year":"2007","unstructured":"Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104\u20139.","journal-title":"Eur Respir J"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","volume":"137","author":"DB Badesch","year":"2010","unstructured":"Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376\u201387.","journal-title":"Chest"},{"issue":"3","key":"94_CR4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/2045-8932.87314","volume":"1","author":"P Sunil","year":"2011","unstructured":"Sunil P, Machado RF, Desai AA. Survival in pulmonary arterial hypertension: a brief review of registry data. Pulm Circ. 2011;1(3):430\u20131.","journal-title":"Pulm Circ"},{"key":"94_CR5","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Euro Heart J 2009;30:2493\u20132537.","DOI":"10.1093\/eurheartj\/ehp297"},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1465-9921-11-12","volume":"11","author":"CJ Ryerson","year":"2010","unstructured":"Ryerson CJ, Nayar S, Swiston JR, Sin DD. Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis. Respir Res. 2010;11:12.","journal-title":"Respir Res"},{"issue":"123","key":"94_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","volume":"21","author":"MD McGoon","year":"2012","unstructured":"McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21(123):8\u201318.","journal-title":"Eur Respir Rev"},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1183\/09059180.00003809","volume":"18","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Negro L, Simonneau G. The use of combination therapy in pulmonary arterial hypertension: new developments. Eur Respir Rev. 2009;18:148\u201353.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"94_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1513\/pats.200504-037SR","volume":"2","author":"ML Toews","year":"2005","unstructured":"Toews ML, Bylund DB. Pharmacologic principles for combination therapy. Proc Am Thorac Soc. 2005;2(4):282\u20139.","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"94_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000334431","volume":"120","author":"Y Bai","year":"2011","unstructured":"Bai Y, Sun L, Hu S, Wei Y. Combination therapy in pulmonary arterial hypertension: a meta-analysis. Cardiology. 2011;120(3):157\u201365.","journal-title":"Cardiology"},{"issue":"8","key":"94_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2011.06.021","volume":"108","author":"BD Fox","year":"2011","unstructured":"Fox BD, Shimony A, Langleben D. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension. Am J Cardiol. 2011;108(8):1177\u201382.","journal-title":"Am J Cardiol"},{"issue":"4","key":"94_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/FJC.0b013e318262a793","volume":"60","author":"B Zhu","year":"2012","unstructured":"Zhu B, Wang L, Sun L, Cao R. Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis. J Cardiovasc Pharmacol. 2012;60(4):342\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"94_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334(5):296\u2013301.","journal-title":"N Engl J Med"},{"issue":"18","key":"94_CR14","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","volume":"55","author":"VV McLaughlin","year":"2010","unstructured":"McLaughlin VV, Benza RL, Rubin LJ, et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial\u2019. J Am Coll Cardiol. 2010;55(18):1915\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"94_CR15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1183\/09031936.00042107","volume":"30","author":"T Thenappan","year":"2007","unstructured":"Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982\u20132006. Eur Respir J. 2007;30(6):1103\u201310.","journal-title":"Eur Respir J"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A, et al. Survival of patients with idiopathic, familial and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156\u201363.","journal-title":"Circulation"},{"issue":"2","key":"94_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"122","author":"RL Benza","year":"2010","unstructured":"Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122(2):164\u201372.","journal-title":"Circulation"},{"issue":"11","key":"94_CR18","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"key":"94_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","volume":"15","author":"SP McKenna","year":"2006","unstructured":"McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15:103\u201315.","journal-title":"Qual Life Res"},{"key":"94_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7525-6-65","volume":"6","author":"SP McKenna","year":"2008","unstructured":"McKenna SP, Ratcliffe J, Meads DM, Brazier JE. Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analysis. Health Qual Life Outcomes. 2008;6:65. doi: 10.1186\/1477-7525-6-65 .","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"94_CR21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1183\/09031936.00069708","volume":"32","author":"DM Meads","year":"2008","unstructured":"Meads DM, McKenna SP, Doughty N, Das C, Gin-Sing W, Langley J, Pepke-Zaba J. The responsiveness and validity of the CAMPHOR Utility Index. Eur Respir J. 2008;32(6):1513\u20139.","journal-title":"Eur Respir J"},{"issue":"1","key":"94_CR22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.healun.2007.10.004","volume":"27","author":"M Gomberg-Maitland","year":"2008","unstructured":"Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads DM, McKenna SP. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). J Heart Lung Transpl. 2008;27(1):124\u201330.","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"94_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1155\/2008\/767126","volume":"15","author":"D Coffin","year":"2008","unstructured":"Coffin D, Duval K, Martel S, et al. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian. Can Respir J. 2008;15(2):77\u201383.","journal-title":"Can Respir J"},{"issue":"1","key":"94_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1477-7525-10-110","volume":"10","author":"K Cima","year":"2012","unstructured":"Cima K, Twiss J, Speich R, et al. The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). Health Qual Life Outcomes. 2012;10(1):110.","journal-title":"Health Qual Life Outcomes"},{"key":"94_CR25","unstructured":"EphMRA Code of Conduct for International Healthcare Market Research, last update 10 September 2010. http:\/\/www.ephmra.org\/code-of-conduct\/2\/A-Purpose-Scope-and-Sources . Accessed 11 Dec 2012."},{"key":"94_CR26","unstructured":"U.S. Department of Health & Human Services, Summary of the HIPAA Privacy Rule 2009. http:\/\/www.hhs.gov\/ocr\/privacy\/ . Accessed 10 Dec 2012."},{"key":"94_CR27","unstructured":"StataCorp. 2011. Stata Statistical Software: Release 12. College Station: StataCorp LP. http:\/\/www.stata.com\/ . Accessed 2 June 2013."},{"issue":"2","key":"94_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCULATIONAHA.110.963983","volume":"122","author":"VV McLaughlin","year":"2010","unstructured":"McLaughlin VV, Suissa S. Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation. 2010;122(2):106\u20138.","journal-title":"Circulation"},{"issue":"18","key":"94_CR29","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","volume":"121","author":"SL Archer","year":"2010","unstructured":"Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation. 2010;121(18):2045\u201366.","journal-title":"Circulation"},{"issue":"16","key":"94_CR30","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250\u201394.","journal-title":"Circulation"},{"issue":"3","key":"94_CR31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000335709","volume":"120","author":"LJ Rubin","year":"2011","unstructured":"Rubin LJ. Combination therapy for pulmonary artery hypertension: what is the evidence? Cardiology. 2011;120(3):172\u20133.","journal-title":"Cardiology"},{"issue":"1","key":"94_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1474515111429649","volume":"11","author":"LA Matura","year":"2012","unstructured":"Matura LA, McDonough A, Carroll DL. Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study. Eur J Cardiovasc Nurs. 2012;11(1):51\u201361.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"8","key":"94_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1403494812464445","volume":"40","author":"N Selimovic","year":"2012","unstructured":"Selimovic N, Rundqvist B, Kj\u00f6rk E, Viriden J, Twiss J, Mckenna SP. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden. Scand J Public Health. 2012;40(8):777\u201383.","journal-title":"Scand J Public Health"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-014-0094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-014-0094-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-014-0094-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:56:05Z","timestamp":1559462165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-014-0094-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s12325-014-0094-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}